BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33951347)

  • 1. Brain MRS correlates with mitochondrial dysfunction biomarkers in MELAS-associated mtDNA mutations.
    Gramegna LL; Evangelisti S; Di Vito L; La Morgia C; Maresca A; Caporali L; Amore G; Talozzi L; Bianchini C; Testa C; Manners DN; Cortesi I; Valentino ML; Liguori R; Carelli V; Tonon C; Lodi R
    Ann Clin Transl Neurol; 2021 Jun; 8(6):1200-1211. PubMed ID: 33951347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic abnormality in acute stroke-like lesion and its relationship with focal cerebral blood flow in patients with MELAS: Evidence from proton MR spectroscopy and arterial spin labeling.
    Wang R; Hu B; Sun C; Geng D; Lin J; Li Y
    Mitochondrion; 2021 Jul; 59():276-282. PubMed ID: 34186261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers.
    Weiduschat N; Kaufmann P; Mao X; Engelstad KM; Hinton V; DiMauro S; De Vivo D; Shungu D
    Neurology; 2014 Mar; 82(9):798-805. PubMed ID: 24477106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.
    Niu FN; Meng HL; Chang LL; Wu HY; Li WP; Liu RY; Wang HT; Zhang B; Xu Y
    CNS Neurosci Ther; 2017 Aug; 23(8):686-697. PubMed ID: 28695670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Serum Biomarkers and Magnetic Resonance Spectroscopy in Monitoring Disease Progression in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Due to mtDNA A3243G Mutation.
    Lee HN; Yoon CS; Lee YM
    Front Neurol; 2018; 9():621. PubMed ID: 30140253
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of familial MELAS: evaluation of A3243G mutation, clinical phenotype, and magnetic resonance spectroscopy-monitored progression.
    Chen C; Xiong N; Wang Y; Xiong J; Huang J; Zhang Z; Wang T
    Neurol India; 2012; 60(1):86-9. PubMed ID: 22406788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
    Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
    Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of magnetic resonance spectroscopy (MRS) with arterial spin labeling (ASL) in the differentiation between mitochondrial encephalomyopathy, lactic Acidosis, plus stroke-like episodes (MELAS) and acute ischemic stroke (AIS).
    Li X; Wang Y; Wang Z; Lu J; Xu Y; Ye J; Kuang Z; Li B; Pan M; Chen W; Lu S; Zhou Z; Cheng L; Wang H
    J Clin Neurosci; 2018 Sep; 55():65-70. PubMed ID: 29921486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
    Burger A; Brooks SJ; Stein DJ; Howells FM
    Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD; Rai GS
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal lobe
    Chen Q; Boeve BF; Tosakulwong N; Lesnick T; Brushaber D; Dheel C; Fields J; Forsberg L; Gavrilova R; Gearhart D; Haley D; Gunter JL; Graff-Radford J; Jones D; Knopman D; Graff-Radford N; Kraft R; Lapid M; Rademakers R; Syrjanen J; Wszolek ZK; Rosen H; Boxer AL; Kantarci K
    Neurology; 2019 Aug; 93(8):e758-e765. PubMed ID: 31315971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular heteroplasmy for disease-associated point mutations in mtDNA: implications for disease expression and evidence for mitotic segregation of heteroplasmic units of mtDNA.
    Matthews PM; Brown RM; Morten K; Marchington D; Poulton J; Brown G
    Hum Genet; 1995 Sep; 96(3):261-8. PubMed ID: 7649539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I; Alkan A; Keskin L; Cikim A; Karakas HM; Firat AK; Sigirci A
    J Diabetes Complications; 2008; 22(4):254-60. PubMed ID: 18413166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.
    Zhong S; Wang Y; Zhao G; Xiang Q; Ling X; Liu S; Huang L; Jia Y
    J Affect Disord; 2014 Oct; 168():380-6. PubMed ID: 25106035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies.
    Shiraiwa N; Ishii A; Iwamoto H; Mizusawa H; Kagawa Y; Ohta S
    J Neurol Sci; 1993 Dec; 120(2):174-9. PubMed ID: 8138807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation.
    Guerrero-Molina MP; Bernabeu-Sanz Á; Ramos-González A; Morales-Conejo M; Delmiro A; Domínguez-González C; Arenas J; Martín MA; González de la Aleja J
    Neuroradiology; 2024 Mar; 66(3):389-398. PubMed ID: 38114794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Variant of MELAS Syndrome With Executive Dysfunction, Heteroplasmic Point Mutation in the
    Endres D; Süß P; Maier SJ; Friedel E; Nickel K; Ziegler C; Fiebich BL; Glocker FX; Stock F; Egger K; Lange T; Dacko M; Venhoff N; Erny D; Doostkam S; Komlosi K; Domschke K; Tebartz van Elst L
    Front Immunol; 2019; 10():412. PubMed ID: 30949164
    [No Abstract]   [Full Text] [Related]  

  • 19. N-acetyl-aspartate levels correlate with intra-axonal compartment parameters from diffusion MRI.
    Grossman EJ; Kirov II; Gonen O; Novikov DS; Davitz MS; Lui YW; Grossman RI; Inglese M; Fieremans E
    Neuroimage; 2015 Sep; 118():334-43. PubMed ID: 26037050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Cerebellar Proton MR Spectroscopy and DWI Study of Patients with Friedreich's Ataxia.
    Gramegna LL; Tonon C; Manners DN; Pini A; Rinaldi R; Zanigni S; Bianchini C; Evangelisti S; Fortuna F; Carelli V; Testa C; Lodi R
    Cerebellum; 2017 Feb; 16(1):82-88. PubMed ID: 26897753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.